Top Markets
Coin of the day
Elevation Oncology, Inc. Elevation Oncology, Inc.

Elevation Oncology, Inc.

ELEV
Rangering i aksjer #29361
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company... Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company operating in the United States, committed to developing targeted cancer therapies for patients with specific genetic profiles. Its leading drug candidate is seribantumab, an anti-HER3 monoclonal antibody currently being evaluated in the Phase II CRESTONE trial. This study focuses on treating advanced solid tumors that harbor a neuregulin-1 fusion. The company was established in 2019 and is headquartered in New York, New York.
Aksjekurs
$0.365
Sist synkronisert: 2025-08-01
Markedsverdi
$21.54M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Elevation Oncology, Inc. (ELEV)

Kategori

Pris ELEV pris med markedsverdi på B
Elevation Oncology, Inc. Elevation Oncology, Inc.
ELEV
$0.365
Markedsverdi av Elevation Oncology, Inc.(ELEV)
Markedsverdi: $21.54M
Per August 2026 har Elevation Oncology, Inc. en markedsverdi på $21.54M. Dette gjør Elevation Oncology, Inc. til det 29361st mest verdifulle selskapet i verden basert på markedsverdi ifølge våre data. Markedsverdi er den totale markedsverdien av et børsnotert selskaps utestående aksjer og brukes vanligvis til å måle hvor mye et selskap er verdt.
Markedsverdihistorikk for Elevation Oncology, Inc. fra 2021 til 2026
ELEV sammenlignet med topp 5 mest populære stocks
Pris på ELEV Eiendel B Markedsverdi for B Resultater
Elevation Oncology, Inc. Elevation Oncology, Inc.
$90,338.83 $21.54M
$5.332T +24,750,264.06%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$77,298.68 $21.54M
$4.562T +21,177,619.30%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$70,177.18 $21.54M
$4.142T +19,226,525.54%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$60,678.09 $21.54M
$3.581T +16,624,033.84%
Elevation Oncology, Inc. Elevation Oncology, Inc.
$47,258.21 $21.54M
$2.789T +12,947,353.94%